(Q35527683)

English

The topoisomerase II catalytic inhibitor ICRF-193 preferentially targets telomeres that are capped by TRF2.

scientific article published on 17 December 2014

Statements

The topoisomerase II catalytic inhibitor ICRF-193 preferentially targets telomeres that are capped by TRF2 (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit